You are here

Hepcidin Lateral Flow Device for Prediction of Acute Kidney Injury

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43DA035750-01
Agency Tracking Number: R43DA035750
Amount: $639,646.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIDA
Solicitation Number: PA12-088
Timeline
Solicitation Year: 2013
Award Year: 2013
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
99 EL CAMINO REAL
MENLO PARK, CA -
United States
DUNS: 145376724
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 CHRISTOPHER DECHARMS
 (650) 585-5303
 cdecharms@omneuron.com
Business Contact
 AMY ROSS
Phone: (650) 315-5452
Email: aross@omneuron.com
Research Institution
 Stub
Abstract

DESCRIPTION (provided by applicant): This Phase I research program will develop a web-based/mobile cognitive therapy program for the treatment of chronic pain. The cognitive therapy strategies used were developed using quantitative patient pain testing andreal-time fMRI brain imaging. Chronic pain is one of the largest public health problems in the United States. Approximately 100 million U.S. adults suffer from chronic pain conditions by NIH estimates, imposing a staggering annual cost of over 500 billion when health care expenditures and lost productivity are considered. In addition, the sharp increase in the use of prescription opioid medication for chronic pain has become a major public health concern. In contrast, growing evidence supports the efficacy and cost-effectiveness of psychosocial and self-management treatment models for pain. There are important advantages to delivering cognitive treatments online, including lower cost, wider availability, uniform delivery, and the ability to tailor treatentprograms to the individual. This research will conduct a randomized, controlled, clinical trial of this novel investigative therapeutic technology. The intervention will focus on improving control over pain and self- management of symptoms. The clinical endpoints are decreased pain symptoms, and improved volitional control over pain. These investigations further the NIH mission by developing a novel therapeutic modality based upon prior neuroimaging research and internet technologies for alleviating a condition which is responsible for substantial human suffering and healthcare cost. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: We plan to develop and test a web-based/mobile cognitive therapy program to facilitate self-management of chronic pain. This is an important clinical application based on neuroimaging and web/mobile technologies that could decrease pain in a large number of patients nationwide at very low cost and low risk. Chronic pain represents one of the most serious public health problems in the United States.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government